Advertisement

Topics

New failure for Auris in tinnitus trial

10:39 EDT 15 Mar 2018 | thePharmaLetter

The future of Keyzilen, an in-ear injection being developed by Auris Medical Holding in acute inner ear

Original Article: New failure for Auris in tinnitus trial

NEXT ARTICLE

More From BioPortfolio on "New failure for Auris in tinnitus trial"

Advertisement
Quick Search
Advertisement
Advertisement